Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancer
Uro-Oncology
Related content
Further Publications Urology
Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
Prostate
Bâcle C, Mazancourt ES, Abid N, Ruffion A, Rouvière O, Colombel M, Fassi-Fehri H
doi: 10.1002/pros.24906
Reproductive Health
Risk factors for pancreatic cancer among non-smokers and non-drinkers of alcohol in the Women's Health Initiative
Cancer Epidemiol Biomarkers Prev
Peila R, Manson JE, Rohan TE
doi: 10.1158/1055-9965.EPI-25-0745
Uro-Oncology
Impact of Intraoperative Opioid Use and a Combined Anesthesia Regimen in Patients Undergoing Radical Prostatectomy for Prostate Cancer in a Single-Center Cohort
J Clin Med
Marcon J, Bischoff R, Rattenhuber K, Chaloupka M, Askari D, Jokisch JF, Becker AJ, Pfitzinger PL, Keller P, Berg E, Stief CG, Siegl D, Kowalski C, Buchner A, Pyrgidis N, Weinhold P
doi: 10.3390/jcm13247506
COMMENTED
Uro-Oncology
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
Eur Urol
Freedland SJ, Mulhall JP, Gleave M, Giorgi U, Saad F, Rannikko A, Ivanova JI, Nasr AF, Reisman AL, Ganguli A, Kral P, Turnbull J, Shore N
doi: 10.1016/j.eururo.2025.02.006
Pregnancy and Childbirth
Gravida and birth outcomes prior to and after diagnosis of early age onset colorectal cancer among female patients: Population-based epidemiologic studies
Cancer Epidemiol Biomarkers Prev
Oveisi N, Sayre EC, Gill S, Cheng V, Cheng V, Brotto LA, Peacock S, McTaggart-Cowan H, Hanley GE, Srikanthan A, De Vera MA
doi: 10.1158/1055-9965.EPI-25-0442
Uro-Oncology
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium
Lancet Oncol
Kishan AU, Sun Y, Tree AC, Hall E, Dearnaley D, Catton CN, Lukka HR, Pond G, Lee WR, Sandler HM, Feng FY, Nguyen PL, Incrocci L, Heemsbergen W, Pos FJ, Horwitz E, Wong JK, Hoffman KE, Hassanzadeh C, Kuban DA, Arcangeli S, Sanguineti G, Supiot S, Crehange G, Latorzeff I, Kalbasi TR, Steinberg ML, Valle LF, Loblaw A, Nikitas J, Roy S, Zaorsky NG, Jia AY, Spratt DE
doi: 10.1016/S1470-2045(25)00034-8
Uro-Oncology
Urinary bladder cancer needs more attention - recommendations for health care professionals and politicians in the European Union
Nat Rev Urol
Ecke TH, Collen S, Filicevas A, Yfantis T, Le Calvez-Kelm F, Jensen BT, van Poppel H
doi: 10.1038/s41585-025-01077-9
Uro-Oncology
Prospective study of endogenous testosterone recovery following neoadjuvant hormonal blockade and radical prostatectomy in high-risk prostate cancer patients
J Sex Med
Nascimento BCG, Pedrenho R, Zandoná PCE, Sanvido LV, Bessa Junior J, Miranda EP, Bastos DA, Cordeiro MD, Coelho R, Nahas WC, Hallak J, Mulhall JP, Gomes CM
doi: 10.1093/jsxmed/qdaf164
Uro-Oncology
Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial
Eur Urol
Palmstedt E, Månsson M, Hugosson J, Arnsrud Godtman R
doi: 10.1016/j.eururo.2025.06.012